featured
Durability of Sacral Neuromodulation Efficacy After Initial Symptom Reduction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurourology and Urodynamics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Is a 50% Improvement Threshold Adequate to Justify Progression From Sacral Neuromodulation Testing to Implant?
Neurourol Urodyn 2021 May 18;[EPub Ahead of Print], DK Charles, RG Everett, ZJ Prebay, TP Landowski, RC O'Connor, ML GuralnickFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.